The Quality Assurance of Vantage Hemp’s Pharma-Grade CBD Extracts
Vantage achieves EU and North American compliance, and internationally recognized pharmaceutical Good Manufacturing Practices (GMP) certifications.
As a strategic pharmaceutical business leader with Canadian, US, and international experience, Greg Rutherford serves as a proven pharmaceutical expert for Vantage’s segment-leading commercial marketing and strategy. Greg has extensive global pharmaceutical experience in launching and commercializing drug assets and in delivering ROI positive, sustainable revenue.
Vantage Hemp Co. Submits a Drug Master File for CBD Distillate to the U.S. Food & Drug Administration
Vantage Hemp Co. further solidifies its position as an industry leader by its announcement of a DMF submission for its CBD distillate to the FDA.
Vantage Hemp Co. is in the Final Stages of its DMF Submissions
As an active pharmaceutical ingredient (API) manufacturer, Vantage prepares for its DMF submissions to the FDA to support the quality and safety of its products.
How to Succeed in the Evolving CBD Pharmaceutical Market
The demand for cannabidiol (CBD) is growing fast in the pharmaceutical sector, thanks to increased awareness among consumers about CBD health benefits.